Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06647251

Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation

Led by Institut Mutualiste Montsouris · Updated on 2024-10-17

90

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Pulmonary vein isolation is the main treatment of paroxysmal and persistent atrial fibrillation. The aim of our study is to prospectively compare the efficacy and safety of the 3 options of radiofrequency delivery with QDOT Micro™, with systematic use of catheter stabilization tools and tighter lesions

CONDITIONS

Official Title

Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient aged 18 or over
  • First atrial fibrillation ablation
  • Paroxysmal atrial fibrillation lasting less than 48 hours
  • Early atrial fibrillation lasting between 7 days and 3 months
  • At least one episode of atrial fibrillation in the year before joining the study
  • Patient affiliated to a health insurance
Not Eligible

You will not qualify if you...

  • History of atrial fibrillation ablation (surgery or catheter)
  • Documented left atrial thrombus
  • Left atrial diameter greater than 60mm, area greater than 35cm2, or volume index greater than 45ml/m2
  • Heart attack, angioplasty, or valve replacement within 3 months before joining
  • Any contraindication to the use of the QDOT MICRO12 bidirectional navigation catheter
  • Patient unable to understand study information
  • Patient deprived of liberty by judicial or administrative decision

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Mutualiste Montsouris

Paris, Paris, France, 75014

Actively Recruiting

Loading map...

Research Team

N

Naly ANDRIAMBAO

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here